Valeant Pharma (VRX) Posts Weaker Q4 EPS; Guides FY11 EPS
Valeant Pharmaceuticals International (NYSE: VRX) reported Q4 EPS ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
